Drug Trial Radar · NCT02435992
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Last checked: Nov 20, 2026Latest source record: Sep 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,012
Actual
Start
Jun 17, 2015
Primary completion
Mar 27, 2020
Study completion Jun 17, 2020
Sponsor
- Lead sponsor
- CelgeneBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- May 6, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC).
Conditions
- Ulcerative Colitis
Interventions
RPC1063Drug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants in Clinical Remission at 10 WeeksTime frame: At 10 Weeks
- Percentage of Participants in Clinical Remission at 52 WeeksTime frame: At 52 Weeks
Locations
372 sites in 30 countries. Site status is shown where the registry gives one.
Arizona Digestive Health
Sun City, Arizona
Adobe Clinical Research LLC
Tucson, Arizona
Arkansas Gastroenterology, P.A.
North Little Rock, Arkansas
Anaheim Clinical Trials
Anaheim, California
Aurora Care Clinic
Costa Mesa, California
Valley View Internal Medicine
Garden Grove, California
Davita Clinical Trials, LLC
Huntington Beach, California
University of California San Diego Medical Center
La Jolla, California
OM Research
Lancaster, California
University of Southern California - Keck School of Medicine
Los Angeles, California
Southern California Research Institute Medical Group, Inc.
Los Angeles, California
Gastrointestinal Biosciences
Los Angeles, California
UCLA Medical Center
Los Angeles, California
Facey Medical Foundation (Parent)
Mission Hills, California
Alliance Clinical Research, LLC
Oceanside, California
Medical Associates Research Group, Inc.
San Diego, California
University of California at San Francisco (PARENT)
San Francisco, California
Medical Research Center of Connecticut, LLC
Hamden, Connecticut
Gastro Florida
Clearwater, Florida
Clinical Research of West Florida Inc - Clearwater
Clearwater, Florida
Advanced Pharma Research, Inc
Delray Beach, Florida
Universal Axon Clinical Research
Doral, Florida
Dolphin Medical Research
Doral, Florida
South Florida Clinical Trials
Hialeah, Florida
Florida Center for Gastroenterology
Largo, Florida
City Medical Group
Miami, Florida
Advanced Clincial Research
Miami, Florida
Advanced Clinical Research of Miami
Miami, Florida
Regenerate Clinical Trials
Miami, Florida
Advanced Research for Health Improvement
Naples, Florida
Advanced Research Institute, Inc.
New Port Richey, Florida
NSB Research
New Smyrna Beach, Florida
Harmony Clinical Research
North Miami Beach, Florida
Med-Care Research
North Miami Beach, Florida
Center For Digestive Health
Orlando, Florida
IMIC, Inc.
Palmetto Bay, Florida
DBC Research, Corp
Pembroke Pines, Florida
Theia Clinical Research, LLC
Pinellas Park, Florida
Florida Medical Clinic, P.A.
Zephyrhills, Florida
Atlanta Gastroenterology Associates LLC
Atlanta, Georgia
Showing 40 of 372 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.